{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:58:11Z","timestamp":1791464291844,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd015173","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000}}],"reference-count":165,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015173.pub2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:22:40Z","timestamp":1764328960000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human stem cells for decompensated cirrhosis in adults"],"prefix":"10.1002","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4789-258X","authenticated-orcid":false,"given":"Htar Htar","family":"Aung","sequence":"additional","affiliation":[{"name":"School of Medicine; IMU University; Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho","family":"Naing","sequence":"additional","affiliation":[{"name":"College of Medicine and Dentistry; James Cook University; Townsville Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Medicine; Newcastle University Medicine Malaysia; Iskandar Puteri, Johor Malaysia"},{"name":"Faculty of Medical Sciences; Newcastle University; Newcastle upon Tyne, NE1 7RU UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saint Nway","family":"Aye","sequence":"additional","affiliation":[{"name":"School of Medicine, IMU University; Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah Htet","family":"Htet","sequence":"additional","affiliation":[{"name":"School of Medicine; IMU University; Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siang Tong","family":"Kew","sequence":"additional","affiliation":[{"name":"School of Medicine; IMU University; Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chavdar S","family":"Pavlov","sequence":"additional","affiliation":[{"name":"Department of Therapy; I.M. Sechenov First Moscow State Medical University; Moscow Russian Federation"},{"name":"Department of Gastroenterology; Botkin Hospital; Moscow Russian Federation"},{"name":"Cochrane Hepato-Biliary Group; Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital \u2014 Rigshospitalet; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"9615","key":"10.1002\/14651858.CD015173.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"4197857","DOI":"10.1155\/2018\/419785","article-title":"Current perspectives regarding stem cell-based therapy for liver cirrhosis","volume":"2018","author":"Kwak","year":"2018","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0004|cit4","volume-title":"Robbins Basic Pathology. Robbins Pathology","author":"Kumar","year":"2017"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12072-018-9865-y","article-title":"The growing burden of liver cirrhosis: implications for preventive measures","volume":"12","author":"Wong","year":"2018","journal-title":"Hepatology International"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3748\/wjg.v5.i4.301","article-title":"Liver biopsy: complications and risk factors","volume":"5","author":"Thampanitchawong","year":"1999","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013532.pub2","article-title":"Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease","author":"Colli","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0011|cit11","first-page":"406","article-title":"Clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/HEP.0000000000000618","article-title":"Noninvasive assessment of hepatic decompensation","volume":"81","author":"Thiele","year":"2025","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010542.pub2","article-title":"Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease","author":"Pavlov","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"7170457","DOI":"10.1155\/2020\/7170457","article-title":"Fluid biomarkers for predicting the prognosis of liver cirrhosis","volume":"2020","author":"Chen","year":"2020","journal-title":"Biochemistry Research International"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0016|cit16","unstructured":"Bambha K Kamath PS Model for End-stage Liver Disease (MELD) - UpToDate www.uptodate.com\/contents\/model-for-end-stage-liver-disease-meld"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/hep.32655","article-title":"Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis","volume":"77","author":"Chang","year":"2023","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","journal-title":"Lancet. Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.08.009","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis (Corrigendum: 2018;69(5):1207)","volume":"69","author":"Angeli","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"26","key":"10.1002\/14651858.CD015173.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","article-title":"Pathophysiology of portal hypertension","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Clinics in Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2005.01211.x","article-title":"The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases","volume":"26","author":"Mayo","year":"2006","journal-title":"Liver International"},{"issue":"4","key":"10.1002\/14651858.CD015173.pub2-BIB0024|cit24","first-page":"222","article-title":"Current concepts in the pathophysiology and management of hepatic encephalopathy","volume":"7","author":"Frederick","year":"2011","journal-title":"Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"156347","DOI":"10.1016\/j.cyto.2023.156347","article-title":"Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis","volume":"170","author":"Pratim Das","year":"2023","journal-title":"Cytokine"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jhep.2006.08.001","article-title":"The intestinal flora and bacterial infection in cirrhosis","volume":"45","author":"Riordan","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/1574888X09666141112114011","article-title":"Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis","volume":"10","author":"Qi","year":"2015","journal-title":"Current Stem Cell Research & Therapy"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/lt.25788","article-title":"Liver transplantation for acute-on-chronic liver failure: science or fiction?","volume":"26","author":"Trebicka","year":"2020","journal-title":"Liver Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/hep.21025","article-title":"Deaths on the liver transplant waiting list: an analysis of competing risks","volume":"43","author":"Kim","year":"2006","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"7","key":"10.1002\/14651858.CD015173.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrgastro.2013.88","article-title":"Liver transplantation: past, present and future","volume":"10","author":"Zarrinpar","year":"2013","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","article-title":"Introduction to stem cell therapy","volume":"24","author":"Biehl","year":"2009","journal-title":"Journal of Cardiovascular and Nursing"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0032|cit32","unstructured":"Brazier Y What are stem cells, and what do they do? https:\/\/www.medicalnewstoday.com\/articles\/323343"},{"issue":"4","key":"10.1002\/14651858.CD015173.pub2-BIB0033|cit33","first-page":"248","article-title":"Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art","volume":"3","author":"Malgieri","year":"2010","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes","volume":"54","author":"Peng","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2468-1253(17)30359-X","article-title":"Haemopoietic stem cell therapy in cirrhosis: the end of the story?","volume":"3","author":"Lanthier","year":"2018","journal-title":"Lancet. Gastroenterology and Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD015173.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.21037\/atm.2020.02.119","article-title":"Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis","volume":"8","author":"Cao","year":"2020","journal-title":"Annals of Translational Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e12712","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Proliferation"},{"issue":"10","key":"10.1002\/14651858.CD015173.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"G791","DOI":"10.1152\/ajpgi.00036.2015","article-title":"Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?","volume":"309","author":"Owen","year":"2015","journal-title":"American Journal of Physiology, Gastrointestinal and Liver Physiology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fcell.2020.594794","article-title":"Molecular pathways modulated by mesenchymal stromal cells and their extracellular vesicles in experimental models of liver fibrosis","volume":"8","author":"Chiabotto","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jcmm.14788","article-title":"Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases","volume":"24","author":"Hu","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13287-022-03041-5","article-title":"Stem cells for treatment of liver fibrosis\/cirrhosis: clinical progress and therapeutic potential","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Research Therapy"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13287-022-03001-z","article-title":"Mesenchymal stromal cells: promising treatment for liver cirrhosis","volume":"13","author":"Yao","year":"2022","journal-title":"Stem Cell Research Therapy"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41232-019-0107-z","article-title":"Mesenchymal stem cell therapies for liver cirrhosis: MSCs as \"conducting cells\" for improvement of liver fibrosis and regeneration","volume":"39","author":"Tsuchiya","year":"2019","journal-title":"Inflammation and Regeneration"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt459","article-title":"Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease","volume":"5","author":"Salama","year":"2014","journal-title":"Stem Cell Research & Therapy"},{"issue":"12","key":"10.1002\/14651858.CD015173.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00595-011-0107-3","article-title":"Are autologous bone marrow stem cell transplantation and transcatheter arterial embolization the best choices for patients with hepatocellular carcinoma and hepatic dysfunction? Report of a case","volume":"42","author":"Huang","year":"2012","journal-title":"Surgery Today"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiol.2431060625","article-title":"Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience","volume":"243","author":"Furst","year":"2007","journal-title":"Radiology"},{"issue":"38","key":"10.1002\/14651858.CD015173.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"14051","DOI":"10.3748\/wjg.v20.i38.14051","article-title":"Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis","volume":"20","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"3945672","DOI":"10.1155\/2019\/3945672","article-title":"Mesenchymal stem cells for liver regeneration in liver failure: from experimental models to clinical trials","volume":"2019","author":"De Miguel","year":"2019","journal-title":"Stem Cells International"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc19127","article-title":"Hematopoietic stem cells and their roles in tissue regeneration","volume":"13","author":"Lee","year":"2020","journal-title":"International Journal of Stem Cells"},{"issue":"7308","key":"10.1002\/14651858.CD015173.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"issue":"24","key":"10.1002\/14651858.CD015173.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.3748\/wjg.v13.i24.3359","article-title":"Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis","volume":"13","author":"Mohamadnejad","year":"2007","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD015173.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3904\/kjim.2015.30.5.580","article-title":"Mesenchymal stem cell therapy for liver fibrosis","volume":"30","author":"Eom","year":"2015","journal-title":"Korean Journal of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2017.09.049","article-title":"Historical perspectives and advances in mesenchymal stem cell research for the treatment of liver diseases","volume":"154","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13770-019-00178-y","article-title":"Stem cell-based therapies for liver diseases: an overview and update","volume":"16","author":"Wang","year":"2019","journal-title":"Tissue Engineering and Regenerative Medicine"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/35018642","article-title":"Hepatocytes from non-hepatic adult stem cells","volume":"406","author":"Alison","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1002\/14651858.CD015173.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4252\/wjsc.v7.i5.859","article-title":"Hepatic stem cells: a viable approach for the treatment of liver cirrhosis","volume":"7","author":"Habeeb","year":"2015","journal-title":"World Journal of Stem Cells"},{"issue":"10","key":"10.1002\/14651858.CD015173.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"26","key":"10.1002\/14651858.CD015173.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"8660","DOI":"10.3748\/wjg.v20.i26.8660","article-title":"Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis","volume":"20","author":"Bai","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","article-title":"Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis","volume":"8","author":"El-Ansary","year":"2012","journal-title":"Stem Cell Reviews and Reports"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet. Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13287-018-0816-2","article-title":"A pooled analysis of mesenchymal stem cell-based therapy for liver disease","volume":"9","author":"Zhao","year":"2018","journal-title":"Stem Cell Research & Therapy"},{"issue":"28","key":"10.1002\/14651858.CD015173.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.3748\/wjg.v21.i28.8697","article-title":"Autologous bone marrow transplantation in decompensated liver: systematic review and meta-analysis","volume":"21","author":"Pankaj","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0063|cit63","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0064|cit64","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0065|cit65","first-page":"n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"10","key":"10.1002\/14651858.CD015173.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015173","article-title":"Human stem cells for decompensated cirrhosis in adults","author":"Aung","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0067|cit67","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0068|cit68","unstructured":"Tsoris A Marlar CA Use of the Child Pugh Score in liver disease (updated 2023 Mar 13) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542308\/ 31194448"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2036.2009.04075.x","article-title":"Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices","volume":"30","author":"Cheung","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD015173.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/jpm.2013.0167","article-title":"Integration of palliative care in end-stage liver disease and liver transplantation","volume":"17","author":"Potosek","year":"2014","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0072|cit72","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6 (R2) database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease-specific questionnaire to measure health-related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi","year":"1999","journal-title":"Gut"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1111\/j.1572-0241.2000.03375.x","article-title":"Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease \u2013 The LDQOL 1.0","volume":"95","author":"Gralnek","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Sherbourne","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0076|cit76","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5.1 Cochrane, 2025 Available from cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0078|cit78","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical Supplement to Chapter 4: Searching for and selecting studies [last updated September 2024]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0079|cit79","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0080|cit80","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0081|cit81","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0082|cit82","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0083|cit83","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0084|cit84","unstructured":"Higgins JP Savovic J Page MJ Sterne JA editor(s); the RoB 2 Development Group Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) sites.google.com\/site\/riskofbiastool\/welcome\/rob-2-0-tool\/current-version-of-rob-2"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0085|cit85","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.11569\/wcjd.v19.i22.2376","article-title":"Efficacy of autologous bone marrow stem cell transplantation via the hepatic artery in combination with octreotide in the management of refractory ascites in patients with hepatic cirrhosis","volume":"19","author":"Fu","year":"2011","journal-title":"World Chinese Journal of Digestology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0087|cit87","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"issue":"24","key":"10.1002\/14651858.CD015173.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0090|cit90","unstructured":"Peryer G Golder S Junqueira D Vohra S Loke YK Chapter 19: Adverse effects [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/liv.12218","article-title":"Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study","volume":"34","author":"Jang","year":"2014","journal-title":"Liver International"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5966\/sctm.2015-0004","article-title":"Intraportal infusion of bone marrow mononuclear or CD133+ cells in patients with decompensated cirrhosis: a double-blind randomized controlled trial","volume":"5","author":"Mohamadnejad","year":"2016","journal-title":"Stem Cells Translational Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0094|cit94","first-page":"12","article-title":"Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis","volume":"14","author":"Nikeghbalian","year":"2011","journal-title":"Archives of Iranian Medicine"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/jgh.14081","article-title":"A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis","volume":"33","author":"Fang","year":"2018","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD015173.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3760\/cma.j.issn.1007-3418.2016.12.006","article-title":"Effect of umbilical cord mesenchymal stem cell transplantation on immune function and prognosis of patients with decompensated hepatitis B cirrhosis","volume":"24","author":"Fang","year":"2016","journal-title":"Zhonghua Gan Zang Bing za Zhi [Chinese Journal of Hepatology]"},{"issue":"4","key":"10.1002\/14651858.CD015173.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.4238\/2014.February.21.13","article-title":"Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis","volume":"13","author":"Liu","year":"2014","journal-title":"Genetics and Molecular Research"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MEG.0b013e32832eb69a","article-title":"Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study","volume":"22","author":"Lyra","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"Mohamadnejad","year":"2013","journal-title":"Liver International"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbmt.2007.12.115","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis","volume":"14","author":"Alimoghaddam","year":"2008","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD015173.pub2-BIB0101|cit101","first-page":"459","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis (Erratum in Archives of Iranian Medicine 2008;11(1):135)","volume":"10","author":"Mohamadnejad","year":"2007","journal-title":"Archives of Iranian Medicine"},{"issue":"42","key":"10.1002\/14651858.CD015173.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3748\/wjg.v16.i42.5297","article-title":"Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease","volume":"16","author":"Salama","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/21.5.837","article-title":"Intention-to-treat analysis: implications for quantitative and qualitative research","volume":"21","author":"Newell","year":"1992","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-118","article-title":"Handling missing data in RCTs; a review of the top medical journals","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD015173.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015524","article-title":"Silymarin for treatment of adults with nonalcoholic fatty liver disease","author":"Wang","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2307\/2982993","article-title":"Publication bias: a problem in interpreting medical data","volume":"151","author":"Begg","year":"1988","journal-title":"Journal of the Royal Statistical Society, Series a (Statistics in Society)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0107|cit107","doi-asserted-by":"crossref","DOI":"10.4159\/9780674040243","volume-title":"Summing Up: the Science of Reviewing Research","author":"Light","year":"1984"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0108|cit108","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0109|cit109","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis [last updated August 2024]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0112|cit112","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD015173.pub2-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD015173.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1186\/1471-230X-10-124","article-title":"Reported methodologic quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"9128","key":"10.1002\/14651858.CD015173.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"35","key":"10.1002\/14651858.CD015173.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015173.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD015173.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.273.5.408","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"7644","key":"10.1002\/14651858.CD015173.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"110","key":"10.1002\/14651858.CD015173.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-018-0770-1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0126|cit126","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 ctu.dk\/tsa\/learn-more"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0130|cit130","unstructured":"TSA \u2013 Trial Sequential Analysis Copenhagen Trial Unit 2021"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0131|cit131","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0132|cit132","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0133|cit133","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2025"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2021.04.014","article-title":"GRADE guidelines 6. Rating the quality of evidence \u2013 imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"e081904","DOI":"10.1136\/bmj-2024-081904","article-title":"Core GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"e081905","DOI":"10.1136\/bmj-2024-081905","article-title":"Core GRADE 3: rating certainty of evidence - assessing inconsistency","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD015173.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"268\u201372","DOI":"10.22074\/cellj.2019.6108","article-title":"Autologous bone marrow stem cell transplantation in liver cirrhosisafter correcting nutritional anomalies, a controlled clinical study","volume":"21","author":"Esmaeilzadeh","year":"2019","journal-title":"Cell Journal"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","article-title":"Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial","volume":"15","author":"Shi","year":"2021","journal-title":"Hepatology International"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0140|cit140","unstructured":"Umbilical cord mesenchymal stem cells for patients with liver cirrhosis clinicaltrials.gov\/study\/NCT01220492?term=NCT01220492&rank=1"},{"issue":"7","key":"10.1002\/14651858.CD015173.pub2-BIB0141|cit141","first-page":"487","article-title":"Safety of human umbilical cord mesenchymal stem cells in treating patients with cirrhotic ascites","volume":"20","author":"Lin","year":"2012","journal-title":"Chinese Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"Spahr","year":"2013","journal-title":"PloS One"},{"issue":"13","key":"10.1002\/14651858.CD015173.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3969\/j.issn.2095-4344.2017.13.014","article-title":"Therapeutic effect of autologous bone marrow mesenchymal stem cell therapy for patients with decompensated hepatitis B: analysis of liver fibrosis, liver function, MELD score and 1-year survival rate","volume":"21","author":"Yang","year":"2017","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0144|cit144","unstructured":"Picot J Cooper K Bryant J Clegg AJ The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation www.ncbi.nlm.nih.gov\/books\/NBK97482\/"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0145|cit145","unstructured":"The effects of umbilical cord blood stem cells in treatment of patients with decompensated HBV-associated liver cirrhosis: a randomized controlled trial www.chictr.org.cn\/hvshowproject.html?id=9539&v=1.0"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0146|cit146","unstructured":"Umbilical cord mesenchymal stem cells infusion via hepatic artery in cirrhosis patients clinicaltrials.gov\/study\/NCT01224327"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0147|cit147","unstructured":"Mesenchymal stem cells treatment for decompensated liver cirrhosis clinicaltrials.gov\/show\/NCT03945487"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0148|cit148","unstructured":"Human umbilical cord-derived mesenchymal stem cells for decompensated cirrhosis (MSC-DLC-2) clinicaltrials.gov\/show\/NCT05224960"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0149|cit149","unstructured":"Treatment with human umbilical cord-derived mesenchymal stem cells for decompensated cirrhosis clinicaltrials.gov\/study\/NCT05121870"},{"issue":"6","key":"10.1002\/14651858.CD015173.pub2-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"e084237","DOI":"10.1136\/bmjopen-2024-084237","article-title":"Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial","volume":"14","author":"Wang","year":"2024","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0151|cit151","unstructured":"Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure clinicaltrials.gov\/study\/NCT05985863"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0152|cit152","unstructured":"Study on the efficacy and safety of autologous bone marrow cell infusion therapy in patients with cirrhosis due to hepatitis C virus https:\/\/trialsearch.who.int\/?TrialID=JPRN-jRCTb060190031"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0153|cit153","unstructured":"Evaluation for the effectiveness and safety for autologous bone marrow cell infusion (ABMi) therapy for HCV infected liver cirrhosis patients - ABMi therapy for liver cirrhosis (HCV) center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000013624"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0154|cit154","unstructured":"Stem cells as an alternative therapy to liver transplantation. A combined experimental study and clinical trial drks.de\/search\/en\/trial\/DRKS00016531"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0155|cit155","unstructured":"Autologous endothelial progenitor cell therapy for reversal of liver cirrhosis clinicaltrials.gov\/study\/NCT03109236"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0156|cit156","unstructured":"Safety and efficacy of SHED for decompensated liver cirrhosis clinicaltrials.gov\/study\/NCT03957655"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0157|cit157","unstructured":"Injectable Collagen Scaffold\u2122 combined with HUC-MSCs transplantation for patients with decompensated cirrhosis clinicaltrials.gov\/study\/NCT02786017"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD015173.pub2-BIB0158|cit158","first-page":"829","article-title":"The observation of clinical effect on treatment of decompensated","volume":"28","author":"Xiao-Zhong","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0159|cit159","first-page":"26","article-title":"The observation of clinical effect on treatment of decompensated cirrhosis with transplantation of autologous bone marrow stem cells via hepatic artery","volume":"19","author":"Li","year":"2018","journal-title":"Journal of Digestive Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015173.pub2-BIB0160|cit160","first-page":"78","article-title":"The observation of clinical effect on treatment of decompensated cirrhosis with transplantation of autologous bone marrow stem cells via hepatic artery","volume":"18","author":"Li","year":"2017","journal-title":"Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jclinepi.2015.12.006","article-title":"Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments","volume":"74","author":"Santesso","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-","article-title":"Evidence at a glance: error matrix approach for overviewing available evidence","volume":"10","author":"Keus","year":"2010","journal-title":"BMC Medical Research Methodology"},{"issue":"5","key":"10.1002\/14651858.CD015173.pub2-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents \u2013 assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015173.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/jgh.14081","article-title":"A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis","volume":"33","author":"Fang","year":"2018","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015173.pub2-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0106-1","article-title":"The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency","volume":"6","author":"Zekri","year":"2015","journal-title":"Stem Cell Research & Therapy"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:17:54Z","timestamp":1791461874000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015173.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":165,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015173.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}